Beijing Beilu Pharmaceutical (300016) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.032x

Based on the latest financial reports, Beijing Beilu Pharmaceutical (300016) has a cash flow conversion efficiency ratio of 0.032x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥74.66 Million ≈ $10.93 Million USD) by net assets (CN¥2.37 Billion ≈ $346.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Beijing Beilu Pharmaceutical for the company's overall valuation and market capitalisation.

Beijing Beilu Pharmaceutical - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Beijing Beilu Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Beijing Beilu Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Beilu Pharmaceutical ranked by their cash flow conversion efficiency. Explore earnings quality score of Beijing Beilu Pharmaceutical to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Zhejiang Anglikang Pharmaceutical Co Ltd Class A
SHE:002940
0.059x
Community West Bancshares
NASDAQ:CWBC
0.018x
Chengdu Huaqi Houpu Holding Co Ltd
SHE:300471
0.017x
Once Upon a Farm, PBC
NYSE:OFRM
0.054x
J.S. Corrugating Machinery Co Ltd
SHE:000821
0.038x
Stratasys Ltd
NASDAQ:SSYS
0.006x
Kvutzat Acro Ltd.
TA:ACRO
-0.030x
SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares
NASDAQ:HDL
0.087x

Annual Cash Flow Conversion Efficiency for Beijing Beilu Pharmaceutical (2006–2024)

The table below shows the annual cash flow conversion efficiency of Beijing Beilu Pharmaceutical from 2006 to 2024. View Beijing Beilu Pharmaceutical share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥1.83 Billion
≈ $267.71 Million
CN¥163.02 Million
≈ $23.86 Million
0.089x +172.27%
2023-12-31 CN¥1.79 Billion
≈ $261.39 Million
CN¥58.46 Million
≈ $8.55 Million
0.033x -50.75%
2022-12-31 CN¥1.92 Billion
≈ $281.43 Million
CN¥127.81 Million
≈ $18.70 Million
0.066x +27.42%
2021-12-31 CN¥2.08 Billion
≈ $305.05 Million
CN¥108.73 Million
≈ $15.91 Million
0.052x -43.93%
2020-12-31 CN¥1.89 Billion
≈ $276.87 Million
CN¥176.00 Million
≈ $25.75 Million
0.093x -13.95%
2019-12-31 CN¥1.45 Billion
≈ $212.25 Million
CN¥156.81 Million
≈ $22.95 Million
0.108x -25.83%
2018-12-31 CN¥1.21 Billion
≈ $176.45 Million
CN¥175.75 Million
≈ $25.72 Million
0.146x +7.54%
2017-12-31 CN¥1.07 Billion
≈ $156.46 Million
CN¥144.92 Million
≈ $21.21 Million
0.136x +60.46%
2016-12-31 CN¥901.69 Million
≈ $131.95 Million
CN¥76.17 Million
≈ $11.15 Million
0.084x -2.56%
2015-12-31 CN¥932.63 Million
≈ $136.47 Million
CN¥80.85 Million
≈ $11.83 Million
0.087x +37.19%
2014-12-31 CN¥666.33 Million
≈ $97.51 Million
CN¥42.11 Million
≈ $6.16 Million
0.063x -14.55%
2013-12-31 CN¥559.38 Million
≈ $81.86 Million
CN¥41.37 Million
≈ $6.05 Million
0.074x +69.54%
2012-12-31 CN¥523.96 Million
≈ $76.67 Million
CN¥22.86 Million
≈ $3.34 Million
0.044x -53.12%
2011-12-31 CN¥491.47 Million
≈ $71.92 Million
CN¥45.73 Million
≈ $6.69 Million
0.093x +15.98%
2010-12-31 CN¥467.62 Million
≈ $68.43 Million
CN¥37.51 Million
≈ $5.49 Million
0.080x -39.92%
2009-12-31 CN¥433.71 Million
≈ $63.46 Million
CN¥57.91 Million
≈ $8.47 Million
0.134x +473.67%
2008-12-31 CN¥133.23 Million
≈ $19.50 Million
CN¥-4.76 Million
≈ $-696.67K
-0.036x -126.30%
2007-12-31 CN¥90.33 Million
≈ $13.22 Million
CN¥12.28 Million
≈ $1.80 Million
0.136x -50.49%
2006-12-31 CN¥71.59 Million
≈ $10.48 Million
CN¥19.65 Million
≈ $2.88 Million
0.274x --

About Beijing Beilu Pharmaceutical

SHE:300016 China Drug Manufacturers - Specialty & Generic
Market Cap
$683.64 Million
CN¥4.67 Billion CNY
Market Cap Rank
#10778 Global
#2960 in China
Share Price
CN¥8.30
Change (1 day)
+2.60%
52-Week Range
CN¥7.23 - CN¥11.19
All Time High
CN¥27.25
About

Beijing Beilu Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products in China. The company provides contrast agents, such as gadopentetate meglumine injection, gadobutrol injection, and gadobenate meglumine injection for MRI contrast; and iohexol injection, iopamidol injection, and iodixanol injection for CT contrast, as well as glimepiride … Read more